Clinical Trial Update: Nutraceutical in Cardiovascular Primary Prevention [Phase 2]

View source ↗

Summary

This clinical trial update indicates a Phase 2 study of a nutraceutical for primary cardiovascular prevention has completed, in participants with hypercholester…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Nutraceutical

Snippet

Sponsor: University Hospital of Ferrara | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED